US 12,465,673 B2
Syringe warmer
David Yuds, Hudson, NH (US); Samiullah K. Durrani, Harvard, MA (US); and Martin Joseph Crnkovich, Walnut Creek, CA (US)
Assigned to Fresenius Medical Care Holdings, Inc., Waltham, MA (US)
Filed by Fresenius Medical Care Holdings, Inc., Waltham, MA (US)
Filed on Jul. 18, 2023, as Appl. No. 18/354,139.
Application 18/354,139 is a division of application No. 16/706,317, filed on Dec. 6, 2019, granted, now 11,806,460.
Prior Publication US 2023/0355855 A1, Nov. 9, 2023
Int. Cl. A61M 1/36 (2006.01); A61M 1/16 (2006.01); A61M 1/34 (2006.01)
CPC A61M 1/3646 (2014.02) [A61M 1/1629 (2014.02); A61M 1/3413 (2013.01); A61M 1/3424 (2014.02); A61M 1/3623 (2022.05); A61M 2205/3331 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/368 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An extracorporeal blood treatment system comprising:
a syringe configured to be filled with fluid received from a fluid line of the extracorporeal blood treatment system;
an extracorporeal blood treatment apparatus comprising a warming chamber configured to receive the syringe and to heat the fluid contained in the syringe; and
a blood component set configured to be coupled to the extracorporeal blood treatment apparatus to convey fluid from a patient, through a dialyzer, and back to the patient during extracorporeal blood treatment, the blood component set comprising an access line;
wherein the syringe is configured to be coupled to the access line following the extracorporeal blood treatment to deliver the fluid from the syringe into the access line to infuse blood to the patient following the extracorporeal blood treatment.